Tailoring anti-infection drug doses right after kidney transplant
This study tests different ways to customize the dose of anti-infection medicines in patients very soon after a kidney transplant to find the safest and most effective dosing. It aims to improve recovery and avoid problems with kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You recently had a kidney transplant (within the last 5 days).
- Your doctors plan to treat you with anti-infection medicines (like antibiotics) for at least 5 days.
- You still have a urinary catheter in place for at least 2 days after surgery to collect urine samples.
- Your new kidney is expected to work soon without needing dialysis right after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different doses of an antibiotic (TMP-SMX) to prevent a serious lung infection called Pneumocystis pneumonia that can occur after kidney transplant. The goal is to find the safest, most effective dose for transplant patients.
This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.
This trial tests whether continuing or stopping a specific antibiotic (TMP-SMX) after the first 6 months can prevent urinary tract infections (UTIs) in kidney transplant recipients who are at high risk for them.
This study tests a new way to monitor levels of your anti-rejection medicines using text messages. It aims to make sure you get the right dose and stay healthy.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
This study tests whether quickly reducing your anti-rejection medicines during a life-threatening ICU stay can help your kidneys recover and improve your overall outcome. It is for kidney transplant recipients with septic shock or severe breathing failure.
Hear when a new Transplant Recipient (Kidney) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.